Literature DB >> 1370586

Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides.

C Boiziau1, N T Thuong, J J Toulmé.   

Abstract

We have demonstrated that the synthesis of cDNA by avian myeloblastosis virus and Moloney murine leukemia virus reverse transcriptases can be prevented by oligonucleotides bound to the RNA template approximately 100 nucleotides remote from the 3' end of the primer. The RNA was truncated at the level of the antisense oligonucleotide-RNA duplex during the reverse transcription. The key role played by the reverse transcriptase-associated RNase H activity in the inhibition process was shown by the use of (i) inhibitors of RNase H (NaF or dAMP), (ii) Moloney murine leukemia virus reverse transcriptase devoid of RNase H activity, or (iii) alpha-analogues of oligomers that do not elicit RNase H-catalyzed RNA degradation. In all three cases the inhibitory effect was either reduced (NaF, dAMP) or totally abolished. However, an alpha-oligomer bound to the sequence immediately adjacent to the primer-binding site prevented reverse transcription. Therefore, initiation of polymerization can be blocked by means of an RNase H-independent mechanism, whereas arrest of a growing cDNA strand can be achieved only by an oligonucleotide mediating cleavage of the template RNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370586      PMCID: PMC48320          DOI: 10.1073/pnas.89.2.768

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Blockage of AMV reverse transcriptase by antisense oligodeoxynucleotides.

Authors:  N Loreau; C Boiziau; P Verspieren; D Shire; J J Toulmé
Journal:  FEBS Lett       Date:  1990-11-12       Impact factor: 4.124

2.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide.

Authors:  C Majumdar; C A Stein; J S Cohen; S Broder; S H Wilson
Journal:  Biochemistry       Date:  1989-02-07       Impact factor: 3.162

4.  Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides.

Authors:  C Cazenave; C A Stein; N Loreau; N T Thuong; L M Neckers; C Subasinghe; C Hélène; J S Cohen; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

5.  Inhibition of DNA synthesis by cross-linking the template to platinum-thiol derivatives of complementary oligodeoxynucleotides.

Authors:  B C Chu; L E Orgel
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

6.  Alpha-DNA.IX: Parallel annealing of alpha-anomeric oligodeoxyribonucleotides to natural mRNA is required for interference in RNase H mediated hydrolysis and reverse transcription.

Authors:  C Gagnor; B Rayner; J P Leonetti; J L Imbach; B Lebleu
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

7.  Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

Authors:  P C Zamecnik; J Goodchild; Y Taguchi; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.

Authors:  M Matsukura; K Shinozuka; G Zon; H Mitsuya; M Reitz; J S Cohen; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene.

Authors:  J A Zaia; J J Rossi; G J Murakawa; P A Spallone; D A Stephens; B E Kaplan; R Eritja; R B Wallace; E M Cantin
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

10.  alpha-DNA II. Synthesis of unnatural alpha-anomeric oligodeoxyribonucleotides containing the four usual bases and study of their substrate activities for nucleases.

Authors:  F Morvan; B Rayner; J L Imbach; S Thenet; J R Bertrand; J Paoletti; C Malvy; C Paoletti
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

View more
  18 in total

Review 1.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

2.  Targeting nucleic acid secondary structures by antisense oligonucleotides designed through in vitro selection.

Authors:  R K Mishra; R Le Tinévez; J J Toulmé
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

3.  Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.

Authors:  S Sei; Q E Yang; D O'Neill; K Yoshimura; K Nagashima; H Mitsuya
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Hirudo medicinalis: a platform for investigating genes in neural repair.

Authors:  W Z Wang; R D Emes; K Christoffers; J Verrall; S E Blackshaw
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

5.  Synthesis and hybridization properties of oligonucleotides containing 2'-O-modified ribonucleotides.

Authors:  T H Keller; R Häner
Journal:  Nucleic Acids Res       Date:  1993-09-25       Impact factor: 16.971

6.  Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs.

Authors:  Jun-ichiro Suzuki; Naoko Miyano-Kurosaki; Tomoyuki Kuwasaki; Hiroaki Takeuchi; Gota Kawai; Hiroshi Takaku
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Dopaminergic regulation of progesterone receptors: brain D5 dopamine receptors mediate induction of lordosis by D1-like agonists in rats.

Authors:  E M Apostolakis; J Garai; C Fox; C L Smith; S J Watson; J H Clark; B W O'Malley
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

8.  In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription.

Authors:  B Bordier; C Hélène; P J Barr; S Litvak; L Sarih-Cottin
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

9.  Inhibition of proopiomelanocortin expression by an oligodeoxynucleotide complementary to beta-endorphin mRNA.

Authors:  S Spampinato; M Canossa; L Carboni; G Campana; G Leanza; S Ferri
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 10.  Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?

Authors:  Elizabeth R Rayburn; Ruiwen Zhang
Journal:  Drug Discov Today       Date:  2008-05-03       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.